Continence triage service direct to GPs.
ID4: Demonstrate the Benefits
Combination of 2 medical devices and web based algorithm to process data. Delivered as a continence triage service direct to GPs - fully developed but not yet implemented.
- Innovation Owner:
- Agnes Crutchard
- Development stage:
- ID4: Demonstrate the Benefits
Continence problems affect 50% of the population at some point. There are currently 2.3 million people being treated by NHS for continence problems and growing at 9% pa. Based on HSG coding/cost data - this costs NHS £280m in 2009 and estimated to cost £400m by 2014.
A continence triage service called Elaros was developed. The service is underpinned by several established technologies which when combined with a Bladder Management software package allow patient data to be digitally recorded and displayed in a clinically valid manor allowing the doctor to make an informed decision about whether to refer or self treat.
(1) 45% of patients referred to outpatient clinic have potential for treatment in community. GP’s using Elaros will be better informed on whether to refer patients (based on NICE guidelines).
(2) Lower initial and follow-up costs (up to a 20-35% reduction in appointment and diagnostic costs).
(3) Clinical utility around replacement of manually logged data (paper diary) with electronic patient data.
(1) Patient has greater involvement with diagnosis and management of condition – evidence to suggest better patient outcomes (Also fits in with PROMs).
(2) Convenience of providing data in comfort of own home.
(3) Avoids unnecessary visit to GP and outpatient clinic
- Clinical outcomes
- Patient experience
- Service efficiency/productivity
- Primary Care